| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/24/2007 | CN1902224A Process for purifying interferon beta |
| 01/24/2007 | CN1902223A Antiviral compositions which inhibit paramyxovirus infection |
| 01/24/2007 | CN1902222A Fc-erythropoietin fusion protein with improved pharmacokinetics |
| 01/24/2007 | CN1902221A Neutralizing epitope-based growth enhancing vaccine |
| 01/24/2007 | CN1902220A Novel agents for the prevention of leishmaniosis |
| 01/24/2007 | CN1902219A Plants having modified growth characteristics and a method for making the same |
| 01/24/2007 | CN1902218A Yeast strains with improved fructose fermentation capacity |
| 01/24/2007 | CN1902217A Novel peptide, process for producing the same and pharmaceutical composition containing the peptide |
| 01/24/2007 | CN1901932A Cytokine antagonist molecules |
| 01/24/2007 | CN1901931A HIV gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus |
| 01/24/2007 | CN1901839A Soluble TCR molecules and methods of use |
| 01/24/2007 | CN1900279A Polynucleotide for inducing apoptosis and its coded polypeptide and use |
| 01/24/2007 | CN1900116A Anti-lymphotoxin-beta receptor antibodies, pharmaceutical composition containing the same and pharmaceutical application thereof |
| 01/24/2007 | CN1900113A Tumor relative polypeptide and its coding gene sequence |
| 01/24/2007 | CN1900112A Plant resistance relative protein and its coding gene and use |
| 01/24/2007 | CN1900111A Recombinant tubercle bacillus antigen poly epitope peptide and its constructing method and use |
| 01/24/2007 | CN1900107A Process for preparing alpha-1-antitrypsin |
| 01/24/2007 | CN1296712C Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins |
| 01/24/2007 | CN1296485C Glutamine-auxotroph human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 01/24/2007 | CN1296482C Pesticidal toxins and nucleotide sequences which encode there toxins |
| 01/24/2007 | CN1296481C Method of increasing fruit size in plant |
| 01/24/2007 | CN1296473C Microorganism producing l-threonine, method of producing the same and method of producing l-threonine using the microorganism |
| 01/24/2007 | CN1296386C Use of CD 25 binding molecules in steroid-resistant patients |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296383C Plant DREB transcription factor and its coding gene and uses |
| 01/24/2007 | CN1296382C The bZIP type transcription factor of corn and its coding gene and the usage thereof |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/23/2007 | US7167801 Method of identifying potential inhibitors of human papillomavirus protein E2 using x-ray atomic coordinates |
| 01/23/2007 | US7166770 Cestrum yellow leaf curling virus promoters |
| 01/23/2007 | US7166769 Nucleotide sequences coding polypeptide for use in the generation of disease resistant plants |
| 01/23/2007 | US7166767 Signal transduction stress-related proteins and methods of use in plants |
| 01/23/2007 | US7166765 Isolated LEC1 transcriptional regulator encoding nucleic acids and methods of use thereof |
| 01/23/2007 | US7166764 Noc2 knockout mouse |
| 01/23/2007 | US7166714 Polynucleotide encoding a STEAP-1 polypeptide, used for diagnosis and treatment of prostate cancer |
| 01/23/2007 | US7166713 Comprises nucleotide sequences coding cleavage stimulation factor (hCstF) for diagnosing male infertility and cancer; contraceptive |
| 01/23/2007 | US7166712 A cDNA encoding a mammalian MDM2 binding protein for modulating the G1 phase of the cell cycle via altering expression and/or activity of a mammalian MDM2 binding protein |
| 01/23/2007 | US7166709 Using high preformance liquid chromatography and gel permeation to purify heat resistant von willebrand factor (VDF) and antihemophilic factor from virally deactivated mixture; treating blood disorders |
| 01/23/2007 | US7166708 Reacting a protein with a hapten (especially a luteinizing hormone releasing hormone peptides derived from E coil, or malaria derived peptides) to produce a hapten-protein conjugate, followed by reacting the hapten-protein conjugate with a polysaccharide |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166705 Histamine receptor antibody |
| 01/23/2007 | US7166704 Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer |
| 01/23/2007 | US7166703 Nucleotide sequences coding polypeptide for use in the treatment of tumors and cell proliferative disorder |
| 01/23/2007 | US7166702 Used to treat inflammatory responses associated with activation, proliferation and migration of immune effector cells, including leukocyte cell types, neutrophils, macrophages, and eosinophils |
| 01/23/2007 | US7166701 Human survivin interacting protein 1 (SIP-1) |
| 01/23/2007 | US7166700 PRO703 Polypeptides |
| 01/23/2007 | US7166699 Mosquito arrestin 1 polypeptides |
| 01/23/2007 | US7166698 Mammalian gene, bcl-w, belongs to the bcl-2 family of apoptosis-controlling genes |
| 01/23/2007 | US7166697 V-like domain binding molecules |
| 01/23/2007 | US7166695 Affinity markers for human serum albumin |
| 01/23/2007 | US7166693 Treating flea allergic dermatitis |
| 01/23/2007 | US7166692 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 01/23/2007 | US7166691 Saposin C and receptors as targets for treatment of benign and malignant disorders |
| 01/23/2007 | US7166578 Orally administered peptides synergize statin activity |
| 01/23/2007 | US7166577 Albumin having enhanced antimicrobial activity |
| 01/23/2007 | US7166576 Methods for preserving organs and tissues |
| 01/23/2007 | US7166575 Compositions and methods for enhanced mucosal delivery of peptide YY and methods for treating and preventing obesity |
| 01/23/2007 | US7166574 Have a hydrophobic linker region and a heparin-binding region, useful as soluble biologics or as surface coatings for medical devices |
| 01/23/2007 | US7166571 Immobilization; antidiabetic agents |
| 01/23/2007 | US7166569 Method for the prevention of transplant rejection |
| 01/23/2007 | US7166568 Compositions and methods to inhibit formation of the C5b-9 complex of complement |
| 01/23/2007 | US7166468 Using nucleic acid fragment; expression cassettes; cell libraries; open reading frames |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166466 Method for creating polynucleotide and polypeptide sequences |
| 01/23/2007 | US7166465 Constitutive promoter from Arabidopsis |
| 01/23/2007 | US7166463 A nucleic acid encoding a modified olfactory cyclic nucleotide-gated ion channel, and the channel contains mutations which together impart increased cyclic AMP sensitivity and decreased cyclic GMP sensitivity |
| 01/23/2007 | US7166461 Animal growth regulator |
| 01/23/2007 | US7166455 A genetic engineered nuclear acids, culturing Bacteroides fragilis, encoding immunomodulator, treating inflammatory bowel disease |
| 01/23/2007 | US7166448 Detecting variant allele of human ferroportin1 gene and evaluating DNA sequence; administering inhibitor of Ferroportin1 iron transport function; oxidative damage in mammals, iron deficiency, hemochromatosis, anemia, and blood disorders; replication |
| 01/23/2007 | US7166446 Vector with nucleotide sequence that comprises a yeast-recognized transcription and translation initiation and termination region; coding amino acid sequence for hybrid precursor polypeptide linked to heterologous mammalian protein such as platelet derived growth factor; genetic engineering |
| 01/23/2007 | US7166444 Nucleic acids encoding chromophores/fluorophores and methods for using the same |
| 01/23/2007 | US7166439 Assay for anti-INGAP antibodies |
| 01/23/2007 | US7166436 Compound for use as diagnostic tool in protein analysis |
| 01/23/2007 | US7166433 Purified nucleic acids encoding transmembrane cochlear-expressed genes; prognosticating and monitoring hearing loss; vectors, cell lines, monoclonal antibodies; genetic engineering |
| 01/23/2007 | US7166426 utilizing a first isolated antigen derived from a region of the hepatitis C virus polyprotein and a multiple epitope fusion antigen; for accurately diagnosing hepatitis C virus infection; solid phase synthesis |
| 01/23/2007 | US7166424 providing methods for designing and engineering fluorescent protein fragments and mutant fragments for protein fragment complementation assays |
| 01/23/2007 | US7166295 Methods of treatment and diagnostic visualization, particularly in cancer |
| 01/23/2007 | US7166291 Allergenic proteins and peptides from dog dander and uses therefor |
| 01/23/2007 | US7166289 Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| 01/23/2007 | US7166284 Completitive binding; immunoassay, immunotherapy |
| 01/23/2007 | US7166278 Using swine organs; controlling gene expression |
| 01/23/2007 | US7166277 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |
| 01/23/2007 | US7166270 Exposing eukaryotic organisms to a single fungal pathogen in the presence of at least one candidate compound; identifying a compound that inhibits fungal pathogen in each of eukaryotic organisms |
| 01/23/2007 | CA2245804C Recombinant ribonuclease proteins |
| 01/18/2007 | WO2007009069A2 Heat lysis production of proteins |
| 01/18/2007 | WO2007009018A2 Il-6 binding proteins |
| 01/18/2007 | WO2007008951A1 Compositions and methods for design of non-immunogenic proteins |
| 01/18/2007 | WO2007008937A2 Adiponectin variants |
| 01/18/2007 | WO2007008933A2 Compositions and methods comprising complex alternative splice variants of myelin/oligodendrocyte genes (mogs) and antibodies directed thereto |
| 01/18/2007 | WO2007008704A2 Melanocortin receptor ligands |
| 01/18/2007 | WO2007008527A2 Chimeric vaccine for haemophilus influenzae-induced disease |
| 01/18/2007 | WO2007008338A1 Egfr inhibitors promote axon regeneration |
| 01/18/2007 | WO2007008071A2 Method for detecting peptides comprising a cross-beta structure |
| 01/18/2007 | WO2007008069A2 A method for detecting peptides comprising a cross-b structure |
| 01/18/2007 | WO2007007777A1 Transgenic non-human mammal capable of expressing non-fluorescent mutant of fluorescent protein |
| 01/18/2007 | WO2007007345A1 Preparation of insulin conjugates |
| 01/18/2007 | WO2007007327A2 Il-32 modulators |
| 01/18/2007 | WO2007007325A2 Sp1 polypeptides, modified sp1 polypeptides and uses thereof |
| 01/18/2007 | WO2007007147A2 Novel bacterial proteins with pesticidal activity |
| 01/18/2007 | WO2007007116A1 Defensin proteins |
| 01/18/2007 | WO2007006808A1 Host cell protein knock-out cells for production of therapeutic proteins |